David Delgrange

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

J. Dubuisson, S. Levy, H. Drobecq, 2008, PloS one.

A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells.

G. Duverlie, C. Wychowski, E. Meurs, 2006, The Journal of general virology.

Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus

E. Blanchard, P. Roingeard, C. Voisset, 2006, Journal of Virology.

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.

J. Dubuisson, G. Duverlie, S. Castelain, 2007, The Journal of general virology.

Inhibition of Hepatitis C Virus Infection in Cell Culture by Small Interfering RNAs

C. Wychowski, Annette Martin, C. Chevalier, 2007, Molecular Therapy.

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry

J. Dubuisson, C. Lecoeur, C. Wychowski, 2009, BMC Microbiology.

Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins

F. Penin, J. Dubuisson, C. Wychowski, 2002, The EMBO journal.